Third doses of COVID-19 vaccines not associated with increase in reports of serious adverse events: study

TORONTO (CTV Network) -- A new study looking at data concerning around 48,000 people in the U.S. has found that third doses of mRNA vaccine, such as those from Pfizer

Related Keywords

Toronto ,Ontario ,Canada , ,Centers For Disease ,Pfizer ,Network Open On ,Zinnia Health ,Mayo Clinic Enterprise ,Disease Control ,Dose ,Vaccine ,Medicine ,Harmacology ,Hospital ,Mmunology ,Natomy ,Ardiology ,Emergency Department ,Booster Shot ,Patient ,Side Effect ,Coronavirus ,